Replies to post #769342 on NorthWest Biotherapeutics Inc (NWBO)

[underpar71]

Except no news is not good news for the stock price or dilution or time that is passing.

[barnstormer]

Jesster - "extra thorough"? Are you suggesting the MHRAs' standard of investigation and evaluation varies by the applicant. I would hope to see a consistent high level applied regardless of the applicant.

[RobotDroid]

The fault lies squarely with the worlds worst mute inept ceo grifter. Her nonmanagement henchmen are also at fault, spewing lies over the years about approval dates and fda submission. L worthless submitted a hugely flawed document and is most likely breaking the law by not disclosing that. Biggest POS team in biotech history.

[Chiugray]

Jesster, Agree, the MHRA is more thorough and undergoes more extensive scrutiny with innovative medicines (e.g., new active substances, advanced therapy medicinal products, vaccines, orphan medicinal products, new combinations) compared to established medicines (e.g., generics, older drugs seeking new indications).